PKM and colorectal carcinoma: Mechanistically, exosomes derived from oxaliplatin-resistant CRC cells bind the chemosensitive cells to deliver hsa_circ_0005963 and promote drug resistance by sponging miR-122 and upregulating PKM2 expression [49].